Edwards Lifescns Rg
EW
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
03/31/2023 - 16:15:00
Bid
03/31/2023 - 16:00:00
Bid
Volume
Ask
03/31/2023 - 16:00:00
Ask
Volume
82.73
+1.16 ( +1.42% )
82.70
3,000
82.71
14,300
More information
Analysis by TheScreener
31.03.2023
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 31.03.2023
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 28.02.2023.
Interest
  Strong
Strong interest since 17.03.2023.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 17.01.2023 at a price of 78.86.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 17.03.2023. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 77.742.
4wk Rel Perf
  -0.66%
 
The four week relative performance versus SP500 is .
Sensibility
  Middle
Moderate, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.16%.
Mkt Cap in $bn
  50.14
With a market capitalization >$8bn, EDWARDS LIFESCIENCES is considered a large-cap stock.
G/PE Ratio
  0.73
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  22.90
The estimated PE is for the year 2025.
LT Growth
  16.62%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
  21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  106
For 1% of index variation, the stock varies on average by 1.06%.
Correlation
  0.62
62.09% of stock movements are explained by index variations.
Value at Risk
  19.36
The value at risk is estimated at USD 19.36. The risk is therefore 23.40%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002